Literature DB >> 12351537

Nitric oxide donors for patients undergoing IVF. A prospective, double-blind, randomized, placebo-controlled trial.

Jeanine Ohl1, Catherine Lefèbvre-Maunoury, Christiane Wittemer, Gabriel Nisand, Marie-Christine Laurent, Pascale Hoffmann.   

Abstract

BACKGROUND: Nitric oxide (NO) is involved in local control of the uterine cycle and in preparation of the uterus for pregnancy. NO donors, acting as vasodilating agents, may therefore have possible therapeutic uses, for example they may be of benefit to patients with a history of implantation failure. In a prospective, comparative, randomized, placebo-controlled study, we assessed the efficacy of nitroglycerin (NTG) administered to 138 IVF patients with a history of implantation failure.
METHODS: Controlled ovarian stimulation was performed with long agonist protocol combined with recombinant FSH. Embryos were transferred on day 2 or 3 after oocyte retrieval. Eligible patients were those who had at least two 'good quality' embryos. The NTG patch was administered the day before embryo transfer and continued until either the results of the pregnancy test were known or until menstruation occurred.
RESULTS: Ovarian response, implantation rate and pregnancy rate were comparable between both groups. No difference was observed in uterine Doppler findings, particularly the mean pulsatility index.
CONCLUSIONS: NTG treatment the day before embryo transfer was no more effective than placebo in improving the implantation or pregnancy rates in a population of IVF patients with a previous history of implantation failures.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12351537     DOI: 10.1093/humrep/17.10.2615

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  6 in total

1.  Circulating nitric oxide in women affected by weight loss amenorrhea during pulsatile gonadotropin-releasing hormone therapy.

Authors:  S Valenti; D Cavallero; L Fazzuoli; F Minuto; M Giusti
Journal:  J Endocrinol Invest       Date:  2005-10       Impact factor: 4.256

2.  Vasodilators for women undergoing fertility treatment.

Authors:  Rosa B Gutarra-Vilchez; Xavier Bonfill Cosp; Demián Glujovsky; Andres Viteri-García; Fernando M Runzer-Colmenares; Maria José Martinez-Zapata
Journal:  Cochrane Database Syst Rev       Date:  2018-10-12

Review 3.  Role of oxidative stress in female reproduction.

Authors:  Ashok Agarwal; Sajal Gupta; Rakesh K Sharma
Journal:  Reprod Biol Endocrinol       Date:  2005-07-14       Impact factor: 5.211

4.  Platelet-rich plasma as an adjuvant in the endometrial preparation of patients with refractory endometrium.

Authors:  Aixa Molina; Jose Sánchez; William Sánchez; Vanessa Vielma
Journal:  JBRA Assist Reprod       Date:  2018-03-01

Review 5.  Add-ons in IVF programme - Hype or Hope?

Authors:  A K Datta; S Campbell; B Deval; G Nargund
Journal:  Facts Views Vis Obgyn       Date:  2015-12-28

Review 6.  Novel Insights on the Role of Nitric Oxide in the Ovary: A Review of the Literature.

Authors:  Maria Cristina Budani; Gian Mario Tiboni
Journal:  Int J Environ Res Public Health       Date:  2021-01-22       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.